等待開盤 06-12 09:30:00 美东时间
+1.760
+1.97%
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
今日重点评级关注:瑞银:维持DraftKings"买入"评级,目标价从43美元升至49美元;Needham:维持Planet Labs"买入"评级,目标价从40美元升至53美元
06-08 11:33
Barclays analyst Alex Scott maintains Voya Financial (NYSE:VOYA) with a Overweight and raises the price target from $89 to $98.
06-05 21:23
激进对冲基金Toms Capital Investment Management周一公开施压Voya Financial,要求这家保险与资产管理公司正式启动...
06-02 03:37
EXCLUSIVE-Activist Toms Capital has built stake in McCormick as it works on Unilever food deal Stake was built after Unilever deal was announced Size of Toms Capital stake not clear Deal has raised concerns about long closing time, structure and antitrust risks By Svea Herbst-Bayliss and Abigail Sum
05-29 21:00
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18
Morgan Stanley analyst Bob Huang maintains Voya Financial (NYSE:VOYA) with a Overweight and raises the price target from $84 to $92.
05-21 22:17
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
RBC Capital analyst Kenneth S. Lee maintains Voya Financial (NYSE:VOYA) with a Outperform and raises the price target from $87 to $91.
05-14 00:01